Prime Editing Unlocks a Universal Strategy for Restoring Lost Proteins
November 22, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Synonyms :
Class :
Brand Name :
Synonyms :
Class :
may enhance the risk of CNS depression when combined with each other
may have an increased effect of a CNS depressant when combined with opioid agonists
may have an increased effect of a CNS depressant when combined with opioid agonists
The interaction may increase the risk of sedation, respiratory depression, and coma
The interaction may increase the risk of sedation, respiratory depression, and coma
The interaction may increase the risk of sedation, respiratory depression, and coma
CNS depressants may increase the CNS depressant effect
may have an increased cns depressive effect when combined with zolpidem
may have an increased CNS depressant effect when combined with oxycodone
may have an increasingly adverse effect when combined with ropeginterferon alfa-2b
may have an increased CNS depressant effect when combined with opioid agonists
may have an increased CNS depressant effect when combined with opioid agonists
may have an increased CNS depressant effect when combined with opioid agonists
may have an increased CNS depressant effect when combined with opioid agonists
flunitrazepam: they may increase the CNS depressant effect of CNS Depressants
buprenorphine,long-acting injectionÂ
may increase the CNS depressant effect of Buprenorphine
may have an increased Effect of a CNS depressant when combined with blonanserin
may increase the risk of CNS depression when combined with 1,2-Benzodiazepine
hydroxyzine: they may increase the CNS depressant effect of CNS Depressants
methotrimeprazine: they may increase the CNS depressant effect of CNS Depressants
clozapine: they may increase the CNS depressant effect of CNS Depressants
secretin: they may increase the CNS depressant effect of CNS Depressants
combining CNS depressants with propoxyphene may result in an additive CNS depression
alvimopan: it may increase the risk of CNS depression
benorilate: it may increase the risk of CNS depression
amobarbital: it may decreased the serum concentration of CNS depressants
may have an increased CNS depressant effect when combined with opioid agonists
may have an increased CNS depressant effect when combined with opioid agonists
CYP3A strong enhancers of the small intestine may reduce the bioavailability of estazolam 
it increases the effect of CNS depressants
it increases the effect of CNS depressants
CNS depressants increase the effect of orphenadrine
it increases the effect of CNS depressants
it increases the efficacy of CNS depressants
may have an increased CNS depressive effect when combined with CNS depressants
may have an increased CNS depressive effect when combined with orphenadrine
may have an increased CNS depressive effect when combined with paraldehyde
may have an increased CNS depressive effect when combined with thalidomide
it increases the effect of CNS depressants
may have an increased CNS depressant effect when combined with flunarizine
azelastine: they may increase the CNS depressant effect of CNS Depressants
olopatadine (Nasal): they may increase the CNS depressant effect of CNS Depressants
azelaic acid: they may increase the CNS depressant effect of CNS Depressants
ipratropium: they may increase the CNS depressant effect of CNS Depressants
naltrexone: they may increase the CNS depressant effect of CNS Depressants
may increase the efficacy of each other when combined
may increase the risk of adverse effect of other CNS depressants
may increase the risk of adverse effect of other CNS depressants
may increase the risk of adverse effect of other CNS depressants
may increase the risk of adverse effect of other CNS depressants
may increase the risk of adverse effect of other CNS depressants
may decrease the serum concentration of estazolam
may decrease the serum concentration of estazolam
may decrease the serum concentration of estazolam
may decrease the serum concentration of estazolam
may decrease the serum concentration of estazolam
may enhance the risk of adverse effect of amphetamines
may enhance the risk of adverse effect of amphetamines
may enhance the risk of adverse effect of amphetamines
may enhance the risk of adverse effect of amphetamines
may enhance the risk of adverse effect of amphetamines
may enhance the CNS depressant effect
may enhance the CNS depressant effect
may enhance the CNS depressant effect
may enhance the CNS depressant effect
may enhance the tachycardic effect
may enhance the tachycardic effect
It may enhance sedation when combined with a shepherd's purse
The potential for increased CNS depression risk or seriousness occurs when estazolam is used together with pinazepam
The potential for increased CNS depression risk or seriousness occurs when estazolam is used together with pipecuronium
When estazolam is used together with bromisoval, the risk or seriousness of CNS depression is enhanced
estazolam has the potential to reduce the rate of excretion of idebenone, leading to an elevation in levels of serum
When estazolam is used together with medazepam, the risk or seriousness of CNS depression is enhanced
The potential for CNS depression may enhanced when estazolam is used together with fencamfamin
When estazolam is used together with niaprazine, the risk or seriousness of CNS depression is enhanced
When estazolam is used together with levosulpiride, the risk or seriousness of CNS depression is enhanced
When estazolam is used together with melitracen, this leads to enhanced risk or seriousness of CNS depression
may enhance the risk of CNS depression when combined with each other
may have an increased CNS depressant effect when combined with alcohol
When estazolam is used together with oleandomycin, this leads to enhanced concentration serum of estazolam
When estazolam is used together with ridaforolimus, this leads to enhanced concentration serum of estazolam
perampanel may enhance the CNS depressant effect of CNS Depressants
may increase the risk of adverse effect of other CNS depressants
may increase the risk of adverse effect of other CNS depressants
may increase the risk of adverse effect of other CNS depressants
may increase the risk of adverse effect of other CNS depressants
may increase the risk of adverse effect of other CNS depressants
it increases the effect of CNS depressants
it increases the effect of CNS depressants
may have an increased CNS depressant effect when combined with CNS depressants
may increase the toxic effect of CNS depressants
may increase the toxic effect of CNS depressants
promethazine/dextromethorphanÂ
may increase the toxic effect of other CNS Depressants
may have an increased CNS depressant effect when combined with CNS depressants
CNS depressants increase the CNS depressing effect of brexanolone
it increases the effect of CNS depressants
ixabepilone: they may increase the CNS depressant effect of CNS Depressants
may increase the serotonergic effects
may increase the serotonergic effects
may increase the serotonergic effects
may increase the serotonergic effects
may have an increased Effect of a CNS depressant when combined with CNS depressants
it increases the toxicity of CNS depressants
CNS depressants increase the effect of sedation of pramipexole
kava: they may increase the CNS depressant effect of CNS Depressants
levothyroxine: they may increase the CNS depressant effect of CNS Depressants
perampanel: they may increase the CNS depressant effect of CNS Depressants
metyrosine: they may increase the CNS depressant effect of CNS Depressants
dasatinib: they may increase the CNS depressant effect of CNS Depressants
nitroglycerin: they may increase the CNS depressant effect of CNS Depressants
ramosetron: they may increase the CNS depressant effect of CNS Depressants
arginine: they may increase the CNS depressant effect of CNS Depressants
diacerein: they may increase the CNS depressant effect of CNS Depressants
aliskiren: they may increase the CNS depressant effect of CNS Depressants
molsidomine: they may increase the CNS depressant effect of CNS Depressants
naftopidil: they may increase the CNS depressant effect of CNS Depressants
urokinase: they may increase the CNS depressant effect of CNS Depressants
sedative effects can be increased when estazolam is administered with papaverine
acebutolol: it may decrease the excretion rate of abacavir CNS depressant
aceclofenac: it may decrease the excretion rate of abacavir CNS depressant
acemetacin: it may decrease the excretion rate of abacavir CNS depressant
acenocoumarol: it may decrease the excretion rate of abacavir CNS depressant
acetohexamide: it may decrease the excretion rate of abacavir CNS depressant
alefacept: it may decrease the excretion rate of abacavir CNS depressant
allopurinol: it may decrease the excretion rate of abacavir CNS depressant
bacitracin: it may decrease the excretion rate of abacavir CNS depressant
baricitinib: it may decrease the excretion rate of abacavir CNS depressant
benazepril: it may decrease the excretion rate of abacavir CNS depressant
benserazide: it may decrease the excretion rate of abacavir CNS depressant
carboplatin: it may increase the risk or severity of CNS depression
bedaquiline: it may increase the risk or severity of CNS depression
agomelatine: it may increase the risk or severity of CNS depression
metocurine: it may increase the risk or severity of CNS depression
amoxicillin: it may increase the risk or severity of CNS depression
benzylpenicillin: it may increase the risk or severity of CNS depression
amphetamine: it may decreased the serum concentration of CNS depressants
cenobamate: it may increase the metabolism of CNS depressants
chlordiazepoxide: it may increase the metabolism of CNS depressants
pergolide: it may increase the risk of CNS depression
this preparation contains diphenhydramine and may enhance the impact of alcohol and other central nervous system depressants, including opioid analgesics, anticonvulsants, antihistamines, antidepressants, antiemetics, anxiolytic sedatives, antipsychotics, and hypnotics
it increases the effect of CNS depressants
CNS depressants increase the effect of buprenorphine
it increases the effect of CNS depressants
it increases the effect of CNS depressants
CNS depressants increase the effect of suvorexant
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
